Exploring the Frontiers of Data and Analytics for Precision Medicine

The frontiers of data sciences and real-world data represent promising areas of innovation and possibility for life sciences and health-care organizations, especially within precision medicine. These areas are continuously evolving, and there are questions about how to navigate this complex and rapidly evolving set of resources, capabilities, and organizations. This webinar, in partnership with the Kraft Precision Medicine Accelerator at the Harvard Business School, aims to provide a landscape of the organizations working in real-world data and advanced analytics, including artificial intelligence and machine learning, and provide commentary on the recent changes to space. It will introduce attendees to the Kraft Precision Medicine Accelerator and teach them about real-world data analytics technologies and data assets that may help advance their research agendas, determine the subject of collaborations, or serve as an investment target.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Coming Down the DSCSA Stretch – Authorized Trading Partners, and What You Need to Know

The Drug Supply Chain Security Act (DSCSA) has its final deadline approaching in November 2023. To confirm that only trusted entities are involved in the exchange of prescription drugs, one of the lesser thought-about elements mandates that the required data exchange through the supply chain is only done with authorized and registered trading partners.
Watch Now

Ensuring Integrity of Drug Formulation from Development to QC

pharmtech

After a small molecule has been identified as a viable drug candidate, substantial testing is required to assure that chemical and structural integrity are preserved throughout the drug development process to maintain its functionality. To keep a balance between quality and manufacturability, time-consuming and labor-intensive testing and analysis are required to demonstrate that chemical integrity is intact. Among the techniques used to study changes in chemical integrity are infrared and Raman spectroscopy. This webcast will discuss where efficiencies can be made in data collection, regulatory compliance, instrument qualification, method validation, and data integrity all along the development pipeline up to final quality control (QC) testing. Learn how to quickly identify changes in polymorphic structure, monitor API to excipient distribution, and troubleshoot out-of-specification (OOS) product lots, while preserving data integrity needed for audits.
Watch Now

Rational Selection and Application of Ready-to-Use Formulations for Self-Emulsifying Drug Delivery Systems

Poorly soluble drugs for oral administration present unique formulation challenges, particularly during early development. Formulation in a lipid-based carrier can be a feasible approach, but usually requires extensive testing to find suitable excipient combination.
Watch Now

APPLYING LOW FREQUENCY RAMAN TO QBD IN PHARMACEUTICAL DEVELOPMENT

biopharma-asia

Low frequency Raman spectroscopy has been used to study various polymorphs and can be applied to the design of crystallization control strategy. Extending the low frequency spectral region to include the fingerprint region provides access to collective vibrations of molecules in the amorphous and crystalline states and yields valuable insight when differentiation of various forms is quintessential.
Watch Now

Spotlight

resources